market insights
Merck’s Multi-Billion-Dollar KEYTRUDA Levels Up with Novel Subcutaneous Delivery, Matching IV Efficacy
2024-11-22
ADC Market Set to Boom: $47 Billion Jump Ahead, but Side Effects Still Pose Key Challenge
2024-11-19
Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?
2024-10-03
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Viking Therapeutics Ready to Make Billions as a Strong Contender in the GLP-1 Weight Loss Space
2024-08-29
LATEST
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1
2025-03-21